327
Views
0
CrossRef citations to date
0
Altmetric
Miscellany

Terms index

Pages 124-125 | Published online: 29 Jul 2009

17a-ethinylestradiol-3-O-sulfate conjugate, 251

Absorption, 51, 134

Acne vulgaris, 175

ACTH, 107

Alcoholic steatosis, 67

Amlodipine, 60

AMP-activated protein kinase, 94

AMPK, 55, 93

Analytical, 56, 59, 62, 78, 114, 136, 137, 140, 162, 172, 175, 178, 181, 226, 240

Antiacne, 175

Antiallergic activity, 87, 88

Antidiabetic, 244

Anti-inflammation, 166

Antimicrobial, 186

Antioxidant, 170

Apoptosis, 98

Bergamottin, 90

Bioavailability, 74, 79, 80, 144, 145, 147, 162, 164, 228, 239, 252

Biomaterial, 146

Borassus flabellifer, 244

Caffeic acid, 197

Caffeine, 107

Calcium availability, 178

Carbamazepine, 148

Caspase 3, 190

Catechol, 115

Cephradine, 238

Chemoprevention, 214

Chinese medicinal formula, 78

Chitosan, 173

Cholangiocarcinoma, 109, 126, 187

Circadian rhythm, 155

Cissus quadrangularis, 170

Clearance prediction, 102, 148, 224, 245

CNS, 127

Colonic drug delivery, 173

Compound action potential, 205

Conjugation reactions and enzymes, 50, 53, 111, 119, 150, 151, 152, 154, 198

Corticosteroe, 107

COX-2, 89

Curcuma comosa, 151, 158

Curcumin, 109

Cyclophosphamide, 118

CYP2C19, 85

CYP2E1, 67

Cytochrome P450, 50, 53, 64, 65, 66, 67, 68, 69, 70, 73,74, 80, 82, 84, 100, 102, 112, 115, 137, 150, 154, 155, 157, 158, 159, 161, 163, 164, 191, 192, 194, 197, 198, 203, 220, 231, 208, 241, 243

Cytotoxicity, 173, 212

Dermopharmacokinetics, 141

Diabetic neuropathy, 190

Diagnostics, 233

Differences in metabolism (species, gender, age, diseases), 70, 71, 121, 123, 220, 228

Disposition, 49, 72, 79, 80, 127, 130, 221, 224, 243, 250, 252, 257

Drug discovery and development, 56, 75, 76, 77, 78, 79, 108, 111, 114, 127, 130, 137, 161, 167, 168, 169, 170, 171, 173, 174, 184, 185, 188, 189, 190, 202, 213, 226, 228

Drug interaction, 49, 51, 63, 68, 73, 74, 82, 84, 102, 130, 132, 158, 164, 165, 191, 192, 194, 245, 255

Drug resistance, 105

Drug uptake, 173

Dry media reaction, 183

ECV304 cells, 170

eNOS, 94

Enteric, 183

Environmental pollution, 118

Enzyme induction, 81, 82, 100, 102, 162, 194, 196, 201

Enzyme inhibition/inactivation, 52, 63, 82, 152, 157, 191, 192, 194, 197, 198, 203, 224

Enzyme kinetics, 85

Epilepsy, 148

Esterification, 183

Extrahepatic metabolism, 52, 63, 111, 152, 154

Faropenem, 61

FAS, 93

Flavin-containing monooxygenase, 121

Free fatty acid, 55

Functional interaction, 150

Gallic acid, 177

Gastric ulcer, 181

Gene expression and regulation, 55, 58, 65, 82, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 106, 152, 157, 199, 200, 235

Genomics/metabonomics/proteomics, 229

Genotoxicity, 170

Ginsenoside Rb1, 58, 71

Glucuronidation, 153

GST, 151

Heavy metal, 138

Helicobacter pylori, 147

Heme oxygenase-1, 58

Hepatocytes, 49, 54, 76, 82, 101, 102, 157, 194, 202, 245, 247, 251

Herbal extract, 186

High-throughput techniques, 56, 104, 114, 226

Houttuynia cordata, 87

HPLC, 60, 61, 177, 238

Hyaluronan, 92

Hydrogen peroxide, 215

Hypertension, 83

IC50, 187

ICP-MS, 138

Imatinib, 73, 74, 79, 80, 164

In silico, 65, 203, 243

In vitro kinetics, 69

In vitro techniques, 54, 59, 69, 70, 72, 78, 101, 104, 105, 108, 115, 133, 137, 141, 150, 162, 166, 172, 173, 178, 189, 191, 201, 204, 205, 213, 233, 245, 247, 250

Inhibition testing, 85

Interleukin, 166, 190

Ion mobility mass spectrometry, 116

Irbesartan, 60

IUGR, 107

Kahweol, 98

Kratom, 205

LC MS new method development, 114

Lipotoxicity, 55

Luteolin, 177

Luteolin-7-O-glucoside, 177

Mangifera indica L., 189

Mangosteen, 175

Mast cells, 87, 88

MASTIC, 147

Mechanism of herb-induced apoptosis, 108

Mechanisms of xenobiotic toxicities, 118

Mechanisms of xenobiotic toxicities, 54, 97, 99, 106, 109, 112, 198, 200, 206, 208, 209, 210, 211, 213, 214, 216, 217, 218

Meridine guide drug, 165

Metabolic profiling, 53, 54, 56, 113, 115, 116, 117, 154, 161, 198, 207, 220, 221

Metabolism, 50, 52, 53, 61, 63, 65, 69, 70, 72, 114, 115, 117, 150, 154, 162, 192, 207, 220, 221, 227, 228, 232

Metalloproteinases, 91

Metastasis, 96

Metformin, 95

Methicillin-resistant Staphylococcus

Microcapsules, 173

Mitragyna speciosa, 205

Mitragynine, 205

MMP-9, 90, 96

Monolithic column, 60

Mulberry, 166

Multifunctional drug delivery, 146

N-acetylglucosamine, 91, 92

Nanoemulsion, 186

Nanoparticle, 75

New LC MS quantitation method, 226

NF-kB, 90, 95

Nitric oxide, 190

Non-P450 phase I enzymes, 117, 121, 228

NQOR, 151

On-line solid-phase extraction, 61

Ovary, 118

Palm fruit fiber, 244

Pentagalloylglucopyranose, 189

PF2D, 101

P-glycoprotein, 95

Pharmacogenetics, 64, 65, 122, 123, 126, 163, 229, 230, 231, 232, 233, 236, 241, 243, 252, 257

Pharmacogenomic propranolol UGT1A, 236

Pharmacokinetic study, 61

Pharmacokinetics and Pharmacodynamics, 49, 51, 72, 78, 104, 105, 123, 127, 128, 129, 130, 131, 145, 172, 192, 219, 220, 226, 238, 232, 239, 240, 241, 242, 243, 245, 252

Phase II drug-metabolizing enzymes, 151

Photoaging, 91

Phyllanthus amarus, 84

Placenta, 111

Placental drug transport, 104

Plasma, 60

Platycodon grandiflorum, 88, 93

Platycodon radix, 67

Polymorphism, 85, 125

Population pharmacokinetic models, 148

Positron emission tomography, 145

Primordial germ cell, 118

Prodrug artifact Prasaplai, 176

Prunella vulgaris, 96

Puerarin, 94

Quality control, 59

Quercetin, 170, 215

Rat, 238

Reactive metabolites, 54, 56

Receptors/nuclear receptors, 199, 123

Redox status, 109

Resveratrol, 165

Rhizome, 138

S-allyl cysteine, 55

Sciatic nerve, 205

Self-microemulsifying drug delivery system (SMEDDS), 147

Shellac, 183

SJS/TEN, 124

Sonneratia caseolaris L., 177

SPE, 60

StAR, 107

STAT3, 98

Substrate selectivity, 153

SULT, 151

Target, 165

TBBPA, 89

Tea polyphenols, 242

Tetrahydrocannabinols, 50

Thai medicinal plants, 135, 187

Thais, 126

Tissue growth factor beta-1, 190

TJ disruption, 215

Tocotrienol, 190

Transporters, 51, 72, 73, 77, 80, 104, 111, 122, 123, 130, 132, 133, 134, 135, 145, 234, 235, 246, 247, 250, 251, 252, 254, 255, 257, 260

Tumor necrosis factor-alpha, 190

UDP-glucuronosyltransferase, 125, 153

UDPGT, 151

Ultraviolet, 91

Uniform design, 172

UVB, 92

Volatile oil, 186

Ya-hom, 181

Zingiberaceae, 138

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.